Myostatin regulates glucose metabolism via the AMP-activated protein kinase pathway in skeletal muscle cells

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 12, 2010, Pages 2072-2081

  Chen, Yuewen ^a   Ye, Jianwei ^a   Cao, Lingzhi ^a   Zhang, Yong ^a   Xia, Weibo ^b   Zhu, Dahai ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

AMPK; Glucose; Glycolysis; Metabolism; Myostatin

Indexed keywords

GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; HEXOKINASE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE; INTERLEUKIN 6; MYOSTATIN;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; GLYCOGEN SYNTHESIS; GLYCOLYSIS; HOMEOSTASIS; METABOLIC REGULATION; MICROARRAY ANALYSIS; MOUSE; MUSCLE MASS; NONHUMAN; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKELETAL MUSCLE; UPREGULATION;

AMP-ACTIVATED PROTEIN KINASES; ANIMALS; CALCIUM-CALMODULIN-DEPENDENT PROTEIN KINASE KINASE; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION PROFILING; GLUCOSE; GLYCOGEN; GLYCOLYSIS; HELA CELLS; HUMANS; INSULIN; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; MYOSTATIN; RATS; SIGNAL TRANSDUCTION;

EID: 78149282298     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.09.017     Document Type: Article

References (39)

1. Carey A.L., Steinberg G.R., Macaulay S.L., Thomas W.G., Holmes A.G., Ramm G., et al. Interleukin-6 increases insulin-stimulated glucose disposal in humans and glucose uptake and fatty acid oxidation in vitro via AMP-activated protein kinase. Diabetes 2006, 55:2688-2697.
2. Ceddia R.B., Somwar R., Maida A., Fang X., Bikopoulos G., Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetologia 2005, 48:132-139.
3. Chen Y., Cao L., Ye J., Zhu D. Upregulation of myostatin gene expression in streptozotocin-induced type 1 diabetes mice is attenuated by insulin. Biochem Biophys Res Commun 2009, 388:112-116.
4. Clop A., Marcq F., Takeda H., Pirottin D., Tordoir X., Bibe B., et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006, 38:813-818.
5. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., et al. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol 2003, 4:P3.
6. Febbraio M.A., Pedersen B.K. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ?. Exerc Sport Sci Rev 2005, 33:114-119.
7. Grobet L., Martin L.J., Poncelet D., Pirottin D., Brouwers B., Riquet J., et al. A deletion in the bovine myostatin gene causes the double-muscled phenotype in cattle. Nat Genet 1997, 17:71-74.
8. Guo T., Jou W., Chanturiya T., Portas J., Gavrilova O., McPherron A.C. Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS ONE 2009, 4:e4937.
9. Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M., et al. Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase. Cell Metab 2005, 2:9-19.
10. Hayashi T., Hirshman M.F., Fujii N., Habinowski S.A., Witters L.A., Goodyear L.J. Metabolic stress and altered glucose transport: activation of AMP-activated protein kinase as a unifying coupling mechanism. Diabetes 2000, 49:527-531.
11. Hittel D.S., Berggren J.R., Shearer J., Boyle K., Houmard J.A. Increased secretion and expression of myostatin in skeletal muscle from extremely obese women. Diabetes 2008.
12. Hocquette J.F., Bas P., Bauchart D., Vermorel M., Geay Y. Fat partitioning and biochemical characteristics of fatty tissues in relation to plasma metabolites and hormones in normal and double-muscled young growing bulls. Comp Biochem Physiol A Mol Integr Physiol 1999, 122:127-138.
13. Holmes B., Dohm G.L. Regulation of GLUT4 gene expression during exercise. Med Sci Sports Exerc 2004, 36:1202-1206.
14. Huang Z., Chen D., Zhang K., Yu B., Chen X., Meng J. Regulation of myostatin signaling by c-Jun N-terminal kinase in C2C12 cells. Cell Signal 2007, 19:2286-2295.
15. Irizarry R.A., Hobbs B., Collin F., Beazer-Barclay Y.D., Antonellis K.J., Scherf U., et al. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 2003, 4:249-264.
16. Jespersen J., Kjaer M., Schjerling P. The possible role of myostatin in skeletal muscle atrophy and cachexia. Scand J Med Sci Sports 2006, 16:74-82.
17. Lin J., Arnold H.B., Della-Fera M.A., Azain M.J., Hartzell D.L., Baile C.A. Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 2002, 291:701-706.
18. Marsin A.S., Bertrand L., Rider M.H., Deprez J., Beauloye C., Vincent M.F., et al. Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia. Curr Biol 2000, 10:1247-1255.
19. McBride A., Ghilagaber S., Nikolaev A., Hardie D.G. The glycogen-binding domain on the AMPK beta subunit allows the kinase to act as a glycogen sensor. Cell Metab 2009, 9:23-34.
20. McFarlane C., Plummer E., Thomas M., Hennebry A., Ashby M., Ling N., et al. Myostatin induces cachexia by activating the ubiquitin proteolytic system through an NF-kappaB-independent, FoxO1-dependent mechanism. J Cell Physiol 2006, 209:501-514.
21. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
22. McPherron A.C., Lee S.J. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002, 109:595-601.
23. Milan G., Dalla Nora E., Pilon C., Pagano C., Granzotto M., Manco M., et al. Changes in muscle myostatin expression in obese subjects after weight loss. J Clin Endocrinol Metab 2004, 89:2724-2727.
24. Pedersen B.K., Edward F. Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J Appl Physiol 2009, 107:1006-1014.
25. Pedersen B.K., Febbraio M.A. Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 2008, 88:1379-1406.
26. Philip B., Lu Z., Gao Y. Regulation of GDF-8 signaling by the p38 MAPK. Cell Signal 2005, 17:365-375.
27. Savage D.B., Zhai L., Ravikumar B., Choi C.S., Snaar J.E., McGuire A.C., et al. A prevalent variant in PPP1R3A impairs glycogen synthesis and reduces muscle glycogen content in humans and mice. PLoS Med 2008, 5:e27.
28. Shelton G.D., Engvall E. Gross muscle hypertrophy in whippet dogs is caused by a mutation in the myostatin gene. Neuromuscul Disord 2007, 17:721-722.
29. Tajmir P., Kwan J.J., Kessas M., Mozammel S., Sweeney G. Acute and chronic leptin treatment mediate contrasting effects on signaling, glucose uptake, and GLUT4 translocation in L6-GLUT4myc myotubes. J Cell Physiol 2003, 197:122-130.
30. Wilkes J.J., Lloyd D.J., Gekakis N. Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 2009, 58:1133-1143.
31. Williams M.S. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004, 351:1030-1031. author reply -1.
32. Winder W.W. Energy-sensing and signaling by AMP-activated protein kinase in skeletal muscle. J Appl Physiol 2001, 91:1017-1028.
33. Woods A., Johnstone S.R., Dickerson K., Leiper F.C., Fryer L.G., Neumann D., et al. LKB1 is the upstream kinase in the AMP-activated protein kinase cascade. Curr Biol 2003, 13:2004-2008.
34. Yang W., Zhang Y., Li Y., Wu Z., Zhu D. Myostatin induces cyclin D1 degradation to cause cell cycle arrest through a phosphatidylinositol 3-kinase/AKT/GSK-3 beta pathway and is antagonized by insulin-like growth factor 1. J Biol Chem 2007, 282:3799-3808.
35. Yang W., Zhang Y., Ma G., Zhao X., Chen Y., Zhu D. Identification of gene expression modifications in myostatin-stimulated myoblasts. Biochem Biophys Res Commun 2005, 326:660-666.
36. Ye J., Zhang Y., Xu J., Zhang Q., Zhu D. FBXO40, a gene encoding a novel muscle-specific F-box protein, is upregulated in denervation-related muscle atrophy. Gene 2007, 404:53-60.
37. Zhao B., Wall R.J., Yang J. Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance. Biochem Biophys Res Commun 2005, 337:248-255.
38. Zhu X., Topouzis S., Liang L.F., Stotish R.L. Myostatin signaling through Smad2, Smad3 and Smad4 is regulated by the inhibitory Smad7 by a negative feedback mechanism. Cytokine 2004, 26:262-272.
39. Zimmers T.A., Davies M.V., Koniaris L.G., Haynes P., Esquela A.F., Tomkinson K.N., et al. Induction of cachexia in mice by systemically administered myostatin. Science 2002, 296:1486-1488.